Literature DB >> 21932189

Significant relationship between platelet activation and apnea-hypopnea index in patients with obstructive sleep apnea syndrome.

Yusuke Kondo1, Ichiro Kuwahira, Mie Shimizu, Asuka Nagai, Tokuzen Iwamoto, Sakurako Kato, Naoki Hayama, Takuya Aoki, Tetsuya Urano, Fumihito Yoshii, Hiroyuki Kobayashi, Tadashi Abe.   

Abstract

Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for arterial thrombosis, which is associated with high cardiovascular morbidity and mortality. To investigate the possible involvement of activated platelets, we evaluated the relationship between severity of OSAS and appearance of platelet aggregates (a marker of activated platelets) in 35 OSAS patients. Platelet aggregates were quantitatively determined by means of flow cytometry. There was a significant correlation between platelet aggregates and apnea-hypopnea index in the severe (AHI≥30 events/hour) group (r=0.756, p<0.001), but not in the mild-moderate (5≤AHI<30 events/hour) group (r=-0.032, p=0.905). The results indicate that the appearance of platelet aggregates increases with an increase in the severity of OSAS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21932189

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  5 in total

1.  Complete blood count alterations after six months of continuous positive airway pressure treatment in patients with severe obstructive sleep apnea.

Authors:  Sinem Nedime Sökücü; Cengiz Ozdemir; Levent Dalar; Levent Karasulu; Senay Aydın; Sedat Altın
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

2.  Increased platelet activation in sleep apnea subjects with intermittent hypoxemia.

Authors:  Ana C Krieger; Ranjini Anand; Evelyn Hernandez-Rosa; Allison Maidman; Sara Milrad; Miles Q DeGrazia; Alexander J Choi; Clara Oromendia; Aaron J Marcus; Joan H F Drosopoulos
Journal:  Sleep Breath       Date:  2020-02-08       Impact factor: 2.816

3.  Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension.

Authors:  Marcia C Feres; Fatima D Cintra; Camila F Rizzi; Luciane Mello-Fujita; Altay A Lino de Souza; Sergio Tufik; Dalva Poyares
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

4.  Is mean platelet volume really a severity marker for obstructive sleep apnea syndrome without comorbidities?

Authors:  Sinem Nedime Sökücü; Cengiz Ozdemir; Levent Dalar; Levent Karasulu; Senay Aydın; Sedat Altın
Journal:  Pulm Med       Date:  2014-09-17

5.  Beyond the absence of sleep disorder: spotlighting the cardiovascular benefits of sleep health.

Authors:  Jenny E Simon
Journal:  Sleep Sci       Date:  2022 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.